Variation Management for Medical Device Registrations in Indonesia

1. Key takeaways

The variation (Variation) process in Indonesia runs on an official assessment clock of 16 working days, and renewal with variation shares the same 16-working-day duration under Permenkes No. 11/2025. A variation can only be handled while the current certificate is valid: once the certificate has lapsed, there is no variation to file, only a new application. The boundary between what can be varied and what must be re-applied for follows a consistent logic: changes to packaging, labelling, added accessories, models, codes or sizes, and certain name or address changes can go through variation, while any change that alters who the product is, who makes it, or what is made requires a fresh application. Changing the licence holder is the case most often underestimated, because it is not a certificate handover but a full re-registration by a new entity, cushioned only by a 6-month stock sell-off right for the outgoing holder.

• Variation assessment clock: 16 working days; renewal with variation: also 16 working days (Permenkes No. 11/2025).
• Variations can only be filed while the certificate is valid; a lapsed certificate leaves only the new application route.
• Variation-eligible changes include packaging, labels, added accessories, models, codes or sizes, principal name or address changes outside M&A, and manufacturer name changes with address and ownership unchanged.
• Re-application is required for product name changes, changing the importer or licence holder, changing the factory or manufacturer, manufacturer address changes, specification changes, raw material or formula changes, and ownership changes through merger or acquisition.
• Changing the licence holder is a full re-registration by the new entity; the outgoing holder may sell remaining stock for 6 months after the new authorisation, with Kemenkes approval.
• Combining variation with renewal is recommended, since the combined filing costs the same tier as a standalone renewal and saves one round of queueing.

2. Legal basis

The timeline provisions are set in Annex 3 of Permenkes No. 11/2025, which fixes the variation assessment clock at 16 working days and renewal with variation at the same 16 working days. The stock sell-off rule derives from Permenkes No. 5/2026 Article 51 paragraph 1 item d, under which an outgoing licence holder may, after the new authorisation has been issued and with Kemenkes approval, continue selling remaining stock for 6 months; the service-standard dimension is reflected in Permenkes No. 11/2025. The boundary between variation and re-application is drawn in the current Kemenkes circulars on variation and re-application situations, while the itemised list for PKRT notification-based changes, with the related implementation notes under UM.01.05/5/0024/2022, provides the reference enumeration. That list originates from the PKRT notification regime, so for devices the specific handling follows the current Kemenkes requirements, but the classification logic is consistent across both regimes: any change that alters who the product is, who makes it, or what is made must be re-applied for rather than varied.

3. Expert insights

The variation-eligible list is worth reading closely. Packaging changes, label changes, and the addition of accessories, models, codes or sizes can be filed as variations. A change to the principal’s name or address is eligible where it does not arise from a merger or acquisition, and a manufacturer name change is eligible where the address and ownership remain unchanged. The re-application list is the mirror image, and it is longer: a product name change, changing the importer or licence holder, changing the factory or manufacturer, a manufacturer address change, a specification change, a raw material or formula change, and a change of company ownership through merger or acquisition. The most frequently underestimated item is the distributor change. In Indonesia, replacing the licence holder is not a matter of handing over a certificate; the new entity walks through the registration process again from the beginning. The only continuity available is commercial rather than regulatory: after the new authorisation has been issued and with Kemenkes approval, the outgoing licence holder may continue selling remaining stock for 6 months under Permenkes 5/2026 Article 51 paragraph 1 item d, read with the service standard of Permenkes 11/2025. On combining filings, the recommendation is to merge variation with renewal: the official fee for renewal with variation sits in the same tier as a standalone renewal, one filing resolves two matters, and one round of queueing disappears. The precondition is discipline about timing, sorting the variation items out well before the renewal window is about to close.

4. Practical recommendations

• Write the variation cooperation obligation into the LoA from the outset: the number of working days after receiving the manufacturer’s variation notice within which the licence holder must file, who bears the costs, and the liability for non-cooperation.
• Use the LoA clause to avoid the later deadlock in which nothing can be changed because the licence holder declines to sign.
• Screen every contemplated change against the variation and re-application lists before committing to a plan, and treat any change to product identity, manufacturer identity or product content as a re-application by default.
• Plan licence holder changes as full re-registration projects with their own timelines and fees, not as certificate transfers, and use the 6-month stock sell-off window only as a bridge.
• Combine variation with renewal where the timing allows, preparing the variation documentation early so the combined filing is ready before the renewal window closes.
• File variations only while the certificate is valid, since a lapsed certificate leaves no variation route at all.

5. Verification checklist

• □ Permenkes No. 11/2025 Annex 3: variation 16 working days, renewal with variation 16 working days.
• □ Permenkes No. 5/2026 Article 51 paragraph 1 item d on authorisation termination and the 6-month stock sell-off.
• □ Current Kemenkes circulars on variation and re-application situations.
• □ PKRT notification-based variation list, with related implementation notes under UM.01.05/5/0024/2022.
• □ Data verified as of October 26, 2026, pending verification against current official sources.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Indonesia. Our team prepares dossiers to ASEAN CSDT structure, manages AKL/AKL-I submissions with Kemenkes, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com